ADAPT Her2-/HR- Study

Project Description

The ADAPT Her2-/HR- Study is a WSG sponsored study, which involves the dynamic testing of Her2-/HR- breast cancer patients. Palleos delivers a full-service management including Data Management, Project Management, Regulatory Affairs, Monitoring, IT infrastructure, site management, and financial management in Germany. For scientific details see the Sponsor’s homepage.

  • 336 Patients, 30-40 Sites [LPI: Q3 2015]
  • Indication: Oncology
  • CRO | Acting as preferred provider for the WSG | Full-service